Hepatoprotective effect of water extract from Chrysanthemum indicum L. flower

Chinese Medicine (United Kingdom)

Volumn 8, Issue 1, 2013, Pages

  Jeong, Sang Chul ^a   Kim, Sang Min ^a   Jeong, Yong Tae ^a   Song, Chi Hyun ^a  

^a Daegu University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYTOCHROME P450 2E1; CYTOCHROME P450 2E1 ANTIBODY; HOT WATER EXTRACT OF CHRYSANTHEMUM INDICUM FLOWER; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; PLANT EXTRACT; SILYMARIN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CELL DAMAGE; CELL STRAIN HEPG2; CHRYSANTHEMUM INDICUM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME ASSAY; FLOWER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SERUM; WESTERN BLOTTING;

EID: 84875687295     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-8-7     Document Type: Article

References (60)

1. Brattin WJ, Glende EA, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. Free Radic Biol Med 1985, 1:27-38.
2. Recknagel RO, Glende EA, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 1989, 43:139-54. 10.1016/0163-7258(89)90050-8, 2675128.
3. Recknagel RO, Glende EA, Britton RS. Free radical damage and lipid peroxidation. Hepatotoxicology 1991, 401-36. Boca Raton: CRC Press, Inc, Meeks RG.
4. Jiangsu new medical college Dictionary of Chinese material medical science and technology 1993, Shanghai: Press of Shanghai, Jiangsu new medical college.
5. Matsuda H, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Medicinal flowers VI. Absolute stereostructures of two new flavanone glycosides and phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L., there inhibitory activities for rat lens aldose reductase. Chem Pharm Bull 2002, 50:972-5. 10.1248/cpb.50.972, 12130858.
6. Kato T, Noguchi K, Miyamoto Y, Suekawa M, Aburada M, Hosoya E, Sakanashi M. Effects of Chrysanthemum indicum Linn. on coronary, vertebral, renal and aortic blood flows of the anesthetized dog. Arch Int Pharmacodyn Ther 1987, 285:288-300.
7. Yu DQ, Xie FZ, He WY, Liang XT. Application of 2D NMR techniques in the structure determination of chrysanthetriol. Yao Xue Xue Bao 1992, 27:191-6.
8. Cheng W, Li J, You T, Hu C. Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linne. J Ethnopharmacol 2005, 101:334-7. 10.1016/j.jep.2005.04.035, 16029939.
9. Shunying Z, Yang Y, Huaidong Y, Yue Y, Guolin Z. Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J Ethnopharmacol 2005, 96:151-8. 10.1016/j.jep.2004.08.031, 15588664.
10. Yan YC, Lou XE, Jiang HD. Experimental studies on the anti-oxidation effects of water extract from Chrysanthemum indicum. Zhong Guo Xian Dai Ying Yong Yao Xue Za Zhi 1999, 16:16-8.
11. Liu YG. Pharmacological study and clinical apply of Chrysanthemum indicum. Shi Zhen Guo Yao 1991, 2:103.
12. Kong LD, Cai Y, Huang WW, Cheng CHK, Tan RX. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 2000, 73:199-207. 10.1016/S0378-8741(00)00305-6, 11025157.
13. Yoshikawa M, Morikawa T, Toguchida I, Harima S, Matsuda H. Medicinal flowers II, Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chem Pharm Bull 2000, 48:651-6. 10.1248/cpb.48.651, 10823701.
14. Kiso Y, Tohkin M, Hikino H. Mechanism of antihepatotoxic activity of glycyrrhizin I, Effect on free radical generation and lipid peroxidation. Planta Med 1984, 50:298-302. 10.1055/s-2007-969714, 6505079.
15. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992, 6:724-30.
16. Raucy JL, Kraner JC, Lasker JM. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 1993, 23:1-20. 10.3109/10408449309104072, 8471158.
17. Zangar RC, Benson JM, Burnett VL, Springer DL. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes. Chem Biol Interact 2000, 125:233-43. 10.1016/S0009-2797(00)00149-6, 10731522.
18. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid, hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999, 105:215-22. 10.1016/S0378-4274(99)00004-1, 10355542.
19. Kim ND, Kwak MK, Kim SG. Inhibition of cytochrome P450 2E1 expression by 2-(allylthio) pyrazine, a potential chemoprotective agent, hepatoprotective effects. Biochem Pharmacol 1997, 53:261-9. 10.1016/S0006-2952(96)00647-8, 9065729.
20. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama, Gonzalez FJ, Peter Guengerich F, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ. The P450 superfamily, Update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol 1991, 10:1-14. 10.1089/dna.1991.10.1, 1991046.
21. Chrungoo VJ, Singh K, Singh J. Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and -galactosamine in freshly isolated rat hepatocytes. Indian J Exp Biol 1997, 35:611-7.
22. Hinkino H, Kiso Y, Wagner H. Anti-hepatotoxic actions of flavonolignans from Silibum marianum fruits. Planta Med 1984, 50:248-50. 10.1055/s-2007-969690, 6091165.
23. Miyazawa T, Suzuki T, Fujimoto K, Kaneda T. Phospholipid hydroperoxide accumulation in liver of rats intoxicated with carbon tetrachloride and its inhibition by dietary alpha-tocopherol. J Biochem 1990, 107:689-93.
24. Shibayama Y. Endotoxaemia and hepatic injury in obstructive jaundice. J Pathol 1989, 159:335-9. 10.1002/path.1711590412, 2614579.
25. Yoshitake I, Ohishi E, Sano J, Mori T, Kubo K. Effects of KF-14363 on liver fibrosis in rats with chronic liver injury induced by carbon tetrachloride. J Pharm Dyn 1991, 14:679-85.
26. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamate oxaloacetate transaminases. Am J Clin Pathol 1957, 28:56-63.
27. Kind PRN, Kings EJ. Determination of serum bilirubin. J Clin Pathol 1976, 7:322-30.
28. Chen J, Mao D, Yong Y, Li J, Wei H, Lu L. Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii. Food Chem 2012, 130:687-94.
29. You YH, Yoo SN, Yoon HG, Park JJ, Lee YH, Kim SO, Oh KT, Lee JG, Cho HY, Jun WJ. In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress. Food Chem Toxicol 2010, 48:1632-7. 10.1016/j.fct.2010.03.037, 20347918.
30. Allis JW, Ward TR, Seely JC, Simmons JE. Toxic effects of carbon tetrachloride on rats. Fundam Appl Toxicol 1990, 15:558-70. 10.1016/0272-0590(90)90041-H, 2258019.
31. Plaa G, Charbonneau M. Detection and evaluation of chemically induced liver injury. Principles and Methods of Toxicology 1994, 841-6. New York: Raven Press, Hayes AW.
32. Drotman RB, Lawhorn GT. Serum enzymes as indicators of chemically induced liver damage. Drug Chem Toxicol 1978, 1:163-71. 10.3109/01480547809034433, 755666.
33. Thabrew MI, Joice PD, Rajatissa W. A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction. Planta Med 1987, 53:239-41. 10.1055/s-2006-962691, 3628555.
34. Alía M, Ramos S, Mateos R, Bravo L, Goya L. Response of the antioxidant defense system to t-Butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol 2005, 19:119-128. 10.1002/jbt.20061, 15849717.
35. Sassa S, Sugita O, Galbraith RA, Kappas A. Drug metabolism by the human hepatoma cell, HepG2 27. Biochem Biophys Res Commun 1987, 143:52-57. 10.1016/0006-291X(87)90628-0, 3030322.
36. Bouma ME, Rogier E, Verthier N, Labarre C, Feldmann G. Further cellular investigation of the human hepatoblastoma-derived cell line HepG2, morphology and immunocytochemical studies of hepatic-secreted proteins. In Vitro Cell Dev Biol 1989, 25:267-275. 10.1007/BF02628465, 2466823.
37. Senthil Kumar KJ, Liao JW, Xiao JH, Gokila Vani M, Wang SY. Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes. Toxicol In Vitro 2012, 26:700-708. 10.1016/j.tiv.2012.03.012, 22484158.
38. Krithika R, Mohankumar R, Verma RJ, Shrivastavc PS, Mohamad IL, Gunasekarand P, Narasimhan S. Isolation, characterization and antioxidative effect of phyllanthin against CCl4-induced toxicity in HepG2 cell line. Chem Biol Interact 2009, 181:351-358. 10.1016/j.cbi.2009.06.014, 19576190.
39. Chen CH, Huang TS, Wong CH, Hong CL, Tsai YH, Liang CC, Lu FJ, Chang WH. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem Toxicol 2009, 47:638-644. 10.1016/j.fct.2008.12.024, 19150384.
40. Crocenzi FA, Roma MG. Silymarin as a new hepatoprotective agent in experimental cholestasis, new possibilities for an ancient medication. Curr Med Chem 2006, 13:1055-1074. 10.2174/092986706776360950, 16611084.
41. Leng-Peschlow E, Strenge-Hesse A. Die Mariendistel (Silybum marianum) und Silymarin als Lebertherapeutikum. Z Phytother 1991, 12:162-174.
42. Shear NH, Malkiewicz IM, Klein D, Koren G, Randor S, Neuman MG. Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line HepG2, in vitro, is diminished by silymarin. Skin Pharmacol 1995, 8:279-91. 10.1159/000211359, 8688194.
43. Dehmlow C, Murawski N, de Groot H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 1996, 58:1591-600. 10.1016/0024-3205(96)00134-8, 8649189.
44. Dehmlow C, Erhard J, de Groot H. Inhibition of kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 1996, 23:749-754. 10.1002/hep.510230415, 8666328.
45. Olnes MI, Kurl RN. Isolation of nuclear extracts from fragile cells, A simplified procedure applied to thymocytes. Biotechniques 1994, 17:828-829.
46. Johansson I, Ingelman-Sundberg M. Carbon tetrachloride-induced lipid peroxidation dependent on an ethanol-inducible form of rabbit liver microsomal cytochrome P450. FEBS Lett 1985, 183:265-9. 10.1016/0014-5793(85)80790-0, 3987892.
47. Brady JF, Xiao F, Wang M, Li Y, Ning SM, Gapac JM, Yang CS. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol Appl Pharmacol 1991, 108:366-73. 10.1016/0041-008X(91)90125-X, 1850173.
48. Kentaro TN, Hiroshi S, Miyuki H. Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products. Food Chem 2009, 116:854-859.
49. Oliva J, Bardag-Gorce F, Tillman B, French SW. Protective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro. Exp Mol Pathol 2011, 90:295-299. 10.1016/j.yexmp.2011.02.006, 3113678, 21352821.
50. Lee KJ, Choi JH, Jeong HG. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 2007, 11:2118-25.
51. Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharm Res 2007, 30:1309-17. 10.1007/BF02980272, 18038910.
52. Allis JW, Brown BL, Simmons JE, Hatch GE, McDonald A, House DE. Methanol potentiation of carbon tetrachloride hepatotoxicity, the central role of cytochrome P450. Toxicology 1996, 112:131-40. 10.1016/0300-483X(96)03366-5, 8814342.
53. Day BJ, Carlson GP, DeNicola DB. Potentiation of carbon tetrachloride-induced hepatotoxicity and pneumotoxicity by pyridine. J Biochem Toxicol 1993, 8:11-8. 10.1002/jbt.2570080104, 8098376.
54. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991, 4:168-79. 10.1021/tx00020a008, 1664256.
55. Anon MT, Ubeda A, Alcaraz MJ. Protective effects of phenolic compounds on CCl4-induced toxicity in isolated rat hepatocytes. Z Naturforsch C 1992, 47:275-9.
56. Brigitte MWR. Oxygen free radicals and antioxidants in cystic fibrosis, the concept of an oxidant-antioxidant imbalance. Acta Paediatr 1994, 83:49-57.
57. Comporti M. Biology of diseases, lipid peroxidation and cellular damage in toxic liver injury. Lab Inves 1985, 53:599-623.
58. Rana SV, Singh SR, Verma S. Mercury induced lipid peroxidation in liver, kidney, brain and gills of a fresh water fish Channa punctatus. Gyoruigaku Zasshi 1995, 42:255-9.
59. Lin SC, Yao CJ, Lin CC, Lin YH. Hepatoprotective activity of Taiwan folk medicine, Eclipta prostrate Linn. against various hapatotoxins induced acute hapatotoxicity. Phytother Res 1996, 10:483-90.
60. Kalyarat K, Kaew K. Antioxidant activity, phenolic content and antimutagenic activity of some water extract of herbs. Thai J Pharm Sci 2006, 30:28-35.